- Safety and effectiveness of monthly intravenous ibandronate injections in a prospective, postmarketing, and observational study in Japanese patients with osteoporosis
-
Takeuchi Y, Hashimoto , Nishida Y, Yamagiwa C, Tamura T, Atsumi A
- KMID: 2437856
- Osteoporos Sarcopenia.
- 2018 Mar;4(1):22-28.
- doi: 10.1016/j.afos.2018.01.001
OBJECTIVES: This postmarketing, observational study evaluated the safety and effectiveness of monthly intravenous (IV) ibandronate in Japanese patients with osteoporosis. METHODS: Eligible patients received monthly IV ibandronate 1mg for 12 months.... -
- CITED
-
- Close
- SHARE
-
- Close
